In 2018 a study by the Emory Eye Center found that chronic exposure to the drug Elmiron causes unique pigmentary maculopathy (eye damage). Recently, long term users of the drug have brought lawsuits alleging that chronic use has led to vision problems.
What Is Elmiron?
Elmiron is the popular brand name for the drug pentosan-polysulfate-sodium. Elmiron is used for the treatment of interstitial-cystitis (IC). IC is a chronic condition that causes bladder pressure, pain, and frequent urination. IC is a common condition that affects men and women, women being more susceptible to IC. It is currently the only oral drug approved to treat pain and discomfort associated with IC.
How Does Elmiron Work?
Researchers believe that the drug works by protecting the bladder from irritants in the urine. IC causes damage to the bladder wall’s protective lining, which allows for irritating bacteria in the urine to cause pain and inflammation. Pentosan-Polysulfate-Sodium creates a protective barrier to the bladder wall to prevent these irritants, and provide relief of symptoms.
Complications of Elmiron:
- Retinal Maculopathy
- Pigmentary Maculopathy
- Retinal Maculitis
- Retinal Macular Degeneration
- Pigmentary Maculitis
- Retinal Pigmentary Endothelium
- Elmiron Toxicity
Elmiron lawsuits include allegations that the manufacturer of Elmiron failed to warn individuals of certain complications, including those related to vision loss. The Manchin Injury Law Group is currently investigating claims on behalf of Elmarion users who have developed vision issues after using Elmiron. If you or a loved one has experienced severe vision changes after taking Elmiron, you may be eligible for an injury compensation claim. Contact us today for a legal consultation with one of our experienced personal injury attorneys to discuss the best course of action for you. Call us today at 800-557-4LAW